ECCA-HIV-ACUPOINT-MAP-0010
HIV-Associated Encephalopathy Acupuncture Point Mapping Atlas
SCF Neural Mapping Schema: Module 10 of Encephalopathy Types
Clinical use classification: Adjunctive supportive neuromodulation only. HIV-associated encephalopathy requires comprehensive infectious disease, neurologic, immunologic, and neurocognitive management including antiretroviral therapy optimization, opportunistic infection evaluation, neuroimaging, CSF studies when indicated, immune-status monitoring, and multidisciplinary HIV care.
The SCF neural mapping method follows the layered model:
acupoint → peripheral nerve branch → dermatome/myotome → spinal or cranial entry → brainstem/hypothalamic/limbic/cortical node → autonomic, neuroimmune, mitochondrial, neurovascular, viral-inflammatory, or connectomic output.
Evidence tiers:
- A = direct mechanistic/tracing evidence
- B = indirect neuroimaging or physiology
- C = anatomy-based inference
I. HIV-Associated Encephalopathy SCF Collapse Targets
ECCA-HIV Collapse Node | Therapeutic Mapping Objective |
Chronic neuroinflammation | Reduce cytokine-glial amplification |
HIV-associated microglial activation | Stabilize neuroimmune signaling |
BBB permeability dysfunction | Support neurovascular integrity |
Viral protein neurotoxicity | Reduce excitotoxic-connectomic stress |
Mitochondrial dysfunction | Restore ATP-redox resilience |
White-matter connectomic degradation | Improve network synchronization |
Limbic-autonomic destabilization | Restore emotional-autonomic regulation |
Dysautonomia | Reinforce cardiovagal synchronization |
Gut-microbiome immune dysregulation | Support gut–immune–brain integration |
Neurocognitive decline | Stabilize cognitive-connectomic coherence |
II. ECCA-HIV Acupoint Neuro-Circuit Atlas
ID | Point | Meridian | Region | Peripheral Nerves | Dermatome | Segment | Central Nodes | Output Circuit | Circuit Network | Evidence |
ECCA-HIV-01 | GV20 | Governing Vessel | Vertex scalp | Greater occipital + trigeminal convergence | CN V / C2 | Cranial-upper cervical | DMN, salience network, PFC | Cortical synchronization | Connectomic-cognitive | B |
ECCA-HIV-02 | GV24 | Governing Vessel | Frontal scalp | Supraorbital nerve | CN V1 | Cranial | Frontal cortex, hypothalamic interface | Executive-network stabilization | Frontal-limbic | C |
ECCA-HIV-03 | EX-HN1 (Sishencong) | Extra points | Peri-vertex scalp | Occipital/trigeminal convergence | C2/CN V | Cranial-upper cervical | DMN-salience integration | Cognitive coherence support | Connectomic-cognitive | C |
ECCA-HIV-04 | Yintang | Extra point | Glabella | Supratrochlear branches | CN V1 | Cranial | Limbic-autonomic circuits | Anxiety/agitation modulation | Limbic-autonomic | C |
ECCA-HIV-05 | GV26 | Governing Vessel | Philtrum | Infraorbital branch | CN V2 | Cranial | Brainstem arousal nuclei | Consciousness/arousal support | Brainstem-arousal | C |
ECCA-HIV-06 | GB20 | Gallbladder | Suboccipital | Greater occipital nerve | C2–C3 | Upper cervical | Brainstem-cerebellar interface | Cervico-brainstem regulation | Cervico-brainstem | C |
ECCA-HIV-07 | BL10 | Bladder | Posterior neck | Cervical dorsal rami | C2–C3 | Upper cervical | Brainstem autonomic nuclei | Cervico-autonomic stabilization | Cervico-autonomic | C |
ECCA-HIV-08 | DU16 | Governing Vessel | Occipital base | Suboccipital nerves | C1–C2 | Upper cervical | Medullary autonomic nuclei | Respiratory-arousal stabilization | Brainstem-autonomic | C |
ECCA-HIV-09 | ST36 | Stomach | Anterolateral leg | Deep peroneal/fascial convergence | L4–L5 | Lumbosacral | NTS, DMV, adrenal pathways | Vagal-adrenal anti-inflammatory reflex | Neuroimmune-metabolic | A |
ECCA-HIV-10 | ST25 | Stomach | Abdomen | Thoracoabdominal afferents | T10–T11 | Thoracic | Enteric-spinal autonomic nodes | Gut-immune-autonomic regulation | Gut-brain-visceral | A |
ECCA-HIV-11 | LI11 | Large Intestine | Lateral elbow | Radial nerve territory | C5–C6 | Cervical | Hypothalamic-inflammatory circuits | Cytokine modulation | Neuroimmune | B |
ECCA-HIV-12 | LI4 | Large Intestine | Dorsal hand | Radial/median overlap | C6–C7 | Cervical | PAG, ACC, insula | Descending analgesia/stress modulation | Nociceptive-limbic | B |
ECCA-HIV-13 | PC6 | Pericardium | Volar forearm | Median nerve | C6–T1 | Cervical-thoracic | NTS, PVN, vagal nuclei | Cardiovagal stabilization | Cardiovagal-autonomic | A/B |
ECCA-HIV-14 | HT7 | Heart | Ulnar wrist | Ulnar nerve territory | C8–T1 | Cervical-thoracic | Limbic-autonomic circuits | Sleep/anxiety-autonomic regulation | Limbic-autonomic | B |
ECCA-HIV-15 | SP6 | Spleen | Medial lower leg | Tibial nerve | L4–S2 | Lumbosacral | Endocrine-autonomic networks | Hormonal-fluid regulation | Endocrine-metabolic | B/C |
ECCA-HIV-16 | KI3 | Kidney | Medial ankle | Tibial/saphenous overlap | L4–S1 | Lumbosacral | Hypothalamic-autonomic systems | ATP-fatigue-fluid support | Renal-endocrine | C |
ECCA-HIV-17 | LV3 | Liver | Dorsal foot | Deep peroneal/tibial overlap | L5–S1 | Lumbosacral | Limbic-hypothalamic nodes | Stress-autonomic modulation | Limbic-autonomic | B/C |
ECCA-HIV-18 | GB34 | Gallbladder | Lateral leg | Common peroneal territory | L4–S1 | Lumbosacral | Basal ganglia-sensorimotor circuits | Motor coordination support | Sensorimotor-basal ganglia | B/C |
ECCA-HIV-19 | BL40 | Bladder | Popliteal fossa | Tibial/common fibular region | L5–S2 | Lumbosacral | Segmental motor circuits | Lower-extremity motor regulation | Sensorimotor | B/C |
ECCA-HIV-20 | CV17 | Conception Vessel | Sternum | Intercostal anterior branches | T2–T5 | Thoracic | Cardiopulmonary brainstem centers | Respiratory-cardiovascular synchronization | Cardiopulmonary-autonomic | C |
ECCA-HIV-21 | BL15 | Bladder | Upper thoracic back | Thoracic dorsal rami | T5–T6 | Thoracic | Cardiovagal autonomic nodes | Cardiovascular-autonomic support | Cardiovagal-visceral | C |
ECCA-HIV-22 | BL20 | Bladder | Mid-thoracic back | Thoracic dorsal rami | T9–T11 | Thoracic | Gut-brain sympathetic interface | Metabolic-gut regulation | Gut-immune-autonomic | C |
ECCA-HIV-23 | CV12 | Conception Vessel | Epigastrium | Intercostal branches | T7–T9 | Thoracic | Brainstem visceral nuclei | Gastric-visceral modulation | Visceral-autonomic | C |
ECCA-HIV-24 | SI3 | Small Intestine | Ulnar hand | Ulnar nerve territory | C8–T1 | Cervical-thoracic | Cervical-spinal sensorimotor circuits | Cervico-fascial integration | Cervico-sensorimotor | C |
ECCA-HIV-25 | BL62 | Bladder | Lateral ankle | Sural/superficial fibular branches | S1–S2 | Lumbosacral | Brainstem-spinal locomotor networks | Gait-postural regulation | Sensorimotor-gait | C |
ECCA-HIV-26 | Taiyang | Extra point | Temporal region | Auriculotemporal + zygomaticotemporal branches | CN V2/V3 | Cranial | Temporal-limbic circuits | Headache/cortical irritability modulation | Temporal-limbic | C |
III. Primary Therapeutic Circuit Stack for HIV-Associated Encephalopathy
SCF Role | Point Cluster | Primary Objective |
Connectomic Stabilizers | GV20, GV24, Sishencong | Cognitive-network stabilization |
Neuroimmune Modulators | ST36, LI11 | Chronic glial-cytokine suppression |
Gut–Immune Regulators | ST25, BL20, CV12 | Gut-microbiome immune modulation |
Cardiovagal Regulators | PC6, CV17, BL15 | Dysautonomia stabilization |
Limbic–Autonomic Regulators | HT7, Yintang, LV3 | Anxiety/depression/autonomic regulation |
Brainstem–Cervical Stabilizers | GB20, BL10, DU16, SI3 | Brainstem-autonomic integration |
Sensorimotor Recovery | GB34, BL40, BL62 | Gait and motor-network support |
Metabolic–Mitochondrial Support | KI3, SP6 | ATP-redox stabilization |
IV. Evidence-Controlled Interpretation
Highest-confidence SCF anchors include:
- ST36 → vagal-adrenal anti-inflammatory circuitry
- ST25 → gut-brain sympathetic modulation
- PC6 → cardiovagal autonomic circuitry
Moderate evidence supports:
- GV20
- HT7
- LI4
- LI11
- GB34
Additional mappings are SCF neuroconnectomic inference models integrating:
- HIV-associated neuroinflammation
- viral protein neurotoxicity
- white-matter connectomics
- microbiome–immune–brain synchronization
- mitochondrial-connectomic stabilization
V. Clinical Deployment Logic
Clinical State | SCF Mapping Priority | Candidate Point Emphasis |
Neurocognitive decline | Connectomic stabilization | GV20, GV24, Sishencong |
Chronic neuroinflammation | Cytokine modulation | ST36, LI11 |
Dysautonomia | Cardiovagal stabilization | PC6, CV17 |
Anxiety/depression overlap | Limbic-autonomic regulation | HT7, Yintang |
Motor slowing / gait dysfunction | Sensorimotor support | GB34, BL40, BL62 |
GI dysbiosis / immune instability | Gut–immune modulation | ST25, BL20 |
Fatigue / mitochondrial decline | ATP-redox support | KI3, SP6 |
Headache / cervical dysregulation | Brainstem-cervical regulation | GB20, BL10 |
VI. Safety and Exclusion Notes
This atlas is not a substitute for:
- antiretroviral therapy
- opportunistic infection treatment
- neuroinfectious disease evaluation
- CSF analysis
- MRI/EEG monitoring
- psychiatric management
- rehabilitation medicine
Urgent escalation is required for:
- rapidly progressive neurologic decline
- seizures
- altered consciousness
- focal deficits
- meningitic signs
- severe autonomic instability
Acupuncture mapping integration should occur only:
- with infectious disease oversight
- after immune-status review
- with platelet/coagulation assessment where indicated
- under multidisciplinary HIV-neurology supervision
MASTER DOCUMENT REGISTRY INDEX
- SCF-ECCA-HIV-ACU-0010 — HIV-Associated Encephalopathy Acupoint Neuro-Circuit Mapping Atlas
- SCF-ECCA-0001 — Encephalopathy Connectomic Collapse Atlas
- SCF-ACU-NEURO-ATLAS-0001-M10 — SCF Acupoint Neuro-Circuit Atlas Module 10
- SCF-361-POINT-NEURAL-MAPPING-0002 — SCF Neural Mapping Schema
- SCF-PATH-PROT-0001 — SCF Pathophysiology Protocol